1. Home
  2. REE vs IRIX Comparison

REE vs IRIX Comparison

Compare REE & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REE Automotive Ltd.

REE

REE Automotive Ltd.

HOLD

Current Price

$0.44

Market Cap

17.1M

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.04

Market Cap

18.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REE
IRIX
Founded
2011
1989
Country
Israel
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1M
18.2M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
REE
IRIX
Price
$0.44
$1.04
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
77.2K
50.0K
Earning Date
06-16-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.85
EPS
N/A
N/A
Revenue
N/A
$41,593,000.00
Revenue This Year
$327.73
$3.07
Revenue Next Year
$36,888.82
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.87
52 Week High
$1.76
$1.65

Technical Indicators

Market Signals
Indicator
REE
IRIX
Relative Strength Index (RSI) 48.74 47.95
Support Level N/A $1.01
Resistance Level $0.49 $1.18
Average True Range (ATR) 0.04 0.03
MACD 0.01 0.01
Stochastic Oscillator 79.73 61.11

Price Performance

Historical Comparison
REE
IRIX

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: